Contact

All Stories

  1. The GPR4 antagonist NE-52-QQ57 increases survival, mitigates the hyperinflammatory response and reduces viral load in SARS-CoV-2-infected K18-hACE2 transgenic mice

    Article • Frontiers in Pharmacology, July 2025, Frontiers

    Dr. Rachel Roper

  2. The GPR4 antagonist NE-52-QQ57 increases survival, mitigates the hyperinflammatory response and reduces viral load in SARS-CoV-2-infected K18-hACE2 transgenic mice

    Article • December 2024, openRxiv

    Dr. Rachel Roper

  3. Comparing and validating air sampling methods for SARS-CoV-2 detection in HVAC ducts of student dorms

    Article • Environmental Pollution, December 2023, Elsevier

    Dr. Rachel Roper

  4. ICTV Virus Taxonomy Profile: Poxviridae 2023

    Article • Journal of General Virology, May 2023, Society for General Microbiology

    Dr. Rachel Roper

  5. Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies

    Article • Vaccine, May 2023, Elsevier

    Dr. Rachel Roper

  6. Waning of SARS-CoV-2 Seropositivity among Healthy Young Adults over Seven Months

    Article • Vaccines, September 2022, MDPI AG

    Dr. Rachel Roper

  7. Loss of SARS-CoV-2 Seropositivity among Healthy Young Adults over Seven Months

    Article • July 2022, openRxiv

    Dr. Rachel Roper

  8. SARS-CoV-2 Detection in Air Samples from Inside Heating, Ventilation, and Air Conditioning (HVAC) Systems- COVID Surveillance in Student Dorms

    Article • American Journal of Infection Control, October 2021, Elsevier

    Dr. Rachel Roper

  9. Discontinuation of Transmission Precautions for COVID-19 Patients

    Article • Infectious Diseases in Clinical Practice, January 2021, Wolters Kluwer Health

    Dr. Rachel Roper

  10. The H-Index in Medicine and Science: Does It Favor H-im or H-er? Successes and Hurdles for Women Faculty

    Article • Digestive Diseases and Sciences, January 2021, Springer Science + Business Media

    Dr. Rachel Roper

  11. Mosquito‐infecting virus Espirito Santo virus inhibits replication and spread of dengue virus

    Article • Journal of Medical Virology, December 2020, Wiley

    Dr. Rachel Roper

  12. Does Gender Bias Still Affect Women in Science?

    Article • Microbiology and Molecular Biology Reviews, July 2019, ASM Journals

    Dr. Rachel Roper

  13. Species-Specific Conservation of Linear Antigenic Sites on Vaccinia Virus A27 Protein Homologs of Orthopoxviruses

    Article • Viruses, May 2019, MDPI AG

    Dr. Rachel Roper

  14. Simple, Rapid Preparation of Poxvirus DNA for PCR Cloning and Analysis

    Article • January 2019, Springer Science + Business Media

    Dr. Rachel Roper

  15. Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer

    Article • PLOS One, February 2018, PLOS

    Dr. Rachel Roper

  16. The effects of diets enriched in omega-3 polyunsaturated fatty acids on systemic vaccinia virus infection

    Article • Scientific Reports, November 2017, Springer Science + Business Media

    Dr. Rachel Roper

  17. Poxvirus Safety Analysis in the Pregnant Mouse Model, Vaccinia, and Raccoonpox Viruses

    Article • January 2017, Springer Science + Business Media

    Dr. Rachel Roper

  18. Murine mesothelin: characterization, expression, and inhibition of tumor growth in a murine model of pancreatic cancer

    Article • Journal of Experimental & Clinical Cancer Research, March 2016, Springer Science + Business Media

    Dr. Rachel Roper

  19. Genome sequence and comparative virulence of raccoonpox virus: the first North American poxvirus sequence

    Article • Journal of General Virology, September 2015, Society for General Microbiology

    Dr Chris Upton, Dr. Rachel Roper

  20. Raccoonpoxvirus safety in immunocompromised and pregnant mouse models

    Article • Vaccine, June 2014, Elsevier

    Dr. Rachel Roper

  21. Antigen Presentation Assays to Investigate Uncharacterized Immunoregulatory Genes

    Article • January 2012, Springer Science + Business Media

    Dr. Rachel Roper

  22. Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching

    Article • Vaccine, April 2011, Elsevier

    Dr. Rachel Roper

  23. Vaccinia virus A35R inhibits MHC class II antigen presentation

    Article • Virology, February 2010, Elsevier

    Dr. Rachel Roper

  24. Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II

    Article • Immunology, November 2009, Wiley

    Dr. Rachel Roper

  25. The Poxvirus A35 Protein Is an Immunoregulator

    Article • Journal of Virology, October 2009, ASM Journals

    Dr. Rachel Roper

  26. Reviews all of the SARS vaccines made for the first SARS Coroavirus

    Article • Expert Review of Vaccines, July 2009, Taylor & Francis

    Dr. Rachel Roper

  27. Two SARS coronavirus vaccines gave protection from disease

    Article • Journal of General Virology, September 2008, Society for General Microbiology

    Dr. Rachel Roper

  28. Genomic differences of Vaccinia virus clones from Dryvax smallpox vaccine: The Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3

    Article • Vaccine, December 2007, Elsevier

    Dr Chris Upton, Dr. Rachel Roper

  29. Unique SARS-CoV protein nsp1: bioinformatics, biochemistry and potential effects on virulence

    Article • Trends in Microbiology, February 2007, Elsevier

    Dr. Rachel Roper

  30. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus

    Article • Journal of General Virology, March 2006, Society for General Microbiology

    Dr. Rachel Roper

  31. Characterization of the Vaccinia Virus A35R Protein and Its Role in Virulence

    Article • Journal of Virology, January 2006, ASM Journals

    Dr. Rachel Roper

  32. The complete sequence of the bovine torovirus genome

    Article • Virus Research, January 2006, Elsevier

    Dr. Rachel Roper

  33. Complete coding sequences of the rabbitpox virus genome

    Article • Journal of General Virology, November 2005, Society for General Microbiology

    Dr Chris Upton, Dr. Rachel Roper

  34. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin

    Article • Virology, September 2005, Elsevier

    Dr Chris Upton, Dr. Rachel Roper

  35. Rapid Response Research - SARS Coronavirus Vaccines and Application of Processes to Other Emerging Infectious Diseases

    Article • Current Immunology Reviews, June 2005, Bentham Science Publishers

    Dr. Rachel Roper

  36. Severe Acute Respiratory Syndrome (SARS): A Year in Review

    Article • Annual Review of Medicine, February 2005, Annual Reviews

    Dr. Rachel Roper

  37. JDotter: a Java interface to multiple dotplots generated by dotter

    Article • Bioinformatics, January 2004, Oxford University Press (OUP)

    Dr. Rachel Roper

  38. Article • BMC Bioinformatics, January 2004, Springer Science + Business Media

    Dr Chris Upton, Dr. Rachel Roper

  39. Rapid Preparation of Vaccinia Virus DNA Template for Analysis and Cloning by PCR

    Article • January 2004, Springer Science + Business Media

    Dr. Rachel Roper

  40. Poxvirus Orthologous Clusters: toward Defining the Minimum Essential Poxvirus Genome

    Article • Journal of Virology, July 2003, ASM Journals

    Dr. Rachel Roper

  41. The Genome Sequence of the SARS-Associated Coronavirus

    Article • Science, May 2003, American Association for the Advancement of Science

    Dr Chris Upton, Dr. Rachel Roper

  42. Prostaglandin E2 and cAMP promote B lymphocyte class switching to IgG1

    Article • Immunology Letters, December 2002, Elsevier

    Dr. Rachel Roper

  43. Poxvirus Orthologous Clusters (POCs)

    Article • Bioinformatics, November 2002, Oxford University Press (OUP)

    Dr. Rachel Roper

  44. Envelope Formation Is Blocked by Mutation of a Sequence Related to the HKD Phospholipid Metabolism Motif in the Vaccinia Virus F13L Protein

    Article • Journal of Virology, February 1999, ASM Journals

    Dr. Rachel Roper

  45. The Envelope Protein Encoded by the A33R Gene Is Required for Formation of Actin-Containing Microvilli and Efficient Cell-to-Cell Spread of Vaccinia Virus

    Article • Journal of Virology, May 1998, ASM Journals

    Dr. Rachel Roper

  46. Mutagenesis of phospholipase D defines a superfamily including a trans-Golgi viral protein required for poxvirus pathogenicity

    Article • The EMBO Journal, August 1997, Wiley

    Dr. Rachel Roper

  47. Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene

    Article • Journal of Virology, June 1996, ASM Journals

    Dr. Rachel Roper

  48. Prostaglandin E2 Inhibits B Lymphocyte Activation by a cAMP-Dependent Mechanism: PGE-Inducible Regulatory Proteins

    Article • Cellular Immunology, April 1994, Elsevier

    Dr. Rachel Roper

  49. A new view of prostaglandin E regulation of the immune response

    Article • Immunology Today, October 1991, Elsevier

    Dr. Rachel Roper

  50. Regulation of B-Cell Tolerance and Triggering by Macrophages and Lymphoid Dendritic Cells

    Article • Immunological Reviews, October 1990, Wiley

    Dr. Rachel Roper